275 related articles for article (PubMed ID: 10566645)
1. Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I.
Stowasser M; Huggard PR; Rossetti TR; Bachmann AW; Gordon RD
J Clin Endocrinol Metab; 1999 Nov; 84(11):4031-6. PubMed ID: 10566645
[TBL] [Abstract][Full Text] [Related]
2. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance.
Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
J Clin Endocrinol Metab; 2000 Jun; 85(6):2160-6. PubMed ID: 10852446
[TBL] [Abstract][Full Text] [Related]
3. Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension.
Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
J Clin Endocrinol Metab; 2000 Sep; 85(9):3313-8. PubMed ID: 10999827
[TBL] [Abstract][Full Text] [Related]
4. In familial hyperaldosteronism type I, hybrid gene-induced aldosterone production dominates that induced by wild-type genes.
Stowasser M; Gartside MG; Taylor WL; Tunny TJ; Gordon RD
J Clin Endocrinol Metab; 1997 Nov; 82(11):3670-6. PubMed ID: 9360524
[TBL] [Abstract][Full Text] [Related]
5. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I.
Stowasser M; Bachmann AW; Jonsson JR; Tunny TJ; Klemm SA; Gordon RD
J Hypertens; 1995 Dec; 13(12 Pt 2):1610-3. PubMed ID: 8903619
[TBL] [Abstract][Full Text] [Related]
6. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
[TBL] [Abstract][Full Text] [Related]
7. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
Stockigt JR; Scoggins BA
J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
[TBL] [Abstract][Full Text] [Related]
8. Primary aldosteronism: learning from the study of familial varieties.
Stowasser M; Gordon RD
J Hypertens; 2000 Sep; 18(9):1165-76. PubMed ID: 10994747
[TBL] [Abstract][Full Text] [Related]
9. Evidence for persistent dysfunction of wild-type aldosterone synthase gene in glucocorticoid-treated familial hyperaldosteronism type I.
Stowasser M; Taylor WL; Gartside MG; Tunny TJ; Gordon RD
J Hypertens; 1997 Dec; 15(12 Pt 2):1729-33. PubMed ID: 9488230
[TBL] [Abstract][Full Text] [Related]
10. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
11. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
12. Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.
Grim CE; Weinberger MH
Pediatrics; 1980 Mar; 65(3):597-604. PubMed ID: 6987607
[TBL] [Abstract][Full Text] [Related]
13. Urinary free cortisol is not a biochemical marker of hypertension.
Krall P; Carvajal C; Ortiz E; Muñoz C; Garrido JL; Mosso L; Fardella C
Am J Hypertens; 2007 Apr; 20(4):459-65. PubMed ID: 17386356
[TBL] [Abstract][Full Text] [Related]
14. Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism.
Gill JR; Bartter FC
J Clin Endocrinol Metab; 1981 Aug; 53(2):331-7. PubMed ID: 6265487
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
[TBL] [Abstract][Full Text] [Related]
16. Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism.
Wisgerhof M; Carpenter PC; Brown RD
J Clin Endocrinol Metab; 1978 Nov; 47(5):938-43. PubMed ID: 400738
[TBL] [Abstract][Full Text] [Related]
17. A new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II.
Fallo F; Sonino N; Armanini D; Luzzi T; Pedini F; Pasini C; Mantero F
Clin Endocrinol (Oxf); 1985 Jun; 22(6):777-85. PubMed ID: 2990765
[TBL] [Abstract][Full Text] [Related]
18. Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation.
Aglony M; Martínez-Aguayo A; Carvajal CA; Campino C; García H; Bancalari R; Bolte L; Avalos C; Loureiro C; Trejo P; Brinkmann K; Giadrosich V; Mericq V; Rocha A; Avila A; Perez V; Inostroza A; Fardella CE
Hypertension; 2011 Jun; 57(6):1117-21. PubMed ID: 21502562
[TBL] [Abstract][Full Text] [Related]
19. The effect of dexamethasone on the control of plasma aldosterone concentration in normal recumbent man.
Weinberger MH; Kem DC; Gomez-Sanchez C; Kramer NJ; Martin BT; Nugent CA
J Lab Clin Med; 1975 Jun; 85(6):957-67. PubMed ID: 166119
[TBL] [Abstract][Full Text] [Related]
20. Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism.
Schambelan M; Brust NL; Chang BC; Slater KL; Biglieri EG
J Clin Endocrinol Metab; 1976 Jul; 43(1):115-31. PubMed ID: 947931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
